Back to Authors

Sato, Kayoko

https://orcid.org/0000-0001-8694-7155

Mayo Clinic

Emory University

Citations 1

TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque
Sato, Kayoko , Niessner, Alexander , Kopecky, Stephen L. , Frye, Robert L. , Weyand, Cornelia M. , Goronzy, Jörg J.

The Journal of Experimental Medicine | January 18, 2006 | Volume: 203 | Issue: 1 | Pages: 239-250

10.1084/jem.20051062 Get It

Acute coronary syndromes (ACS) are precipitated by a rupture of the atherosclerotic plaque, often at the site of T cell and macrophage infiltration. Here, we show that plaque-infiltrating CD4 T cells effectively kill vascular smooth muscle cells (VSMC). VSMCs sensitive to T cell–mediated killing express the death receptor DR5 (TNF-related apoptosis-inducing ligand [TRAIL] receptor 2), and anti-TRAIL and anti-DR5 antibodies block T cell–mediated apoptosis. CD4 T cells that express TRAIL upon stimulation are expanded in patients with ACS and more effectively induce VSMC apoptosis. Adoptive transfer of plaque-derived CD4 T cells into immunodeficient mice that are engrafted with human atherosclerotic plaque results in apoptosis of VSMCs, which was prevented by coadministration of anti-TRAIL antibody. These data identify that the death pathway is triggered by TRAIL-producing CD4 T cells as a direct mechanism of VSMC apoptosis, a process which may lead to plaque destabilization.